Polymyalgia rheumatica
31 results
1 - 31
EULAR/ACR guideline on managing patients with polymyalgia rheumatica- Tocilizumab beneficial for adults with persistent polymyalgia rheumatica symptoms who receive steroid therapy
- Sarilumab increases remission, decreases steroid dose in polymyalgia rheumatica taper, but at a high cost (SAPHYR)
- Secukinumab plus shortened glucocorticoid taper increases sustained remission in relapsed polymyalgia rheumatica (NNT = 5)